CSIMarket


Actavis Plc  (ACT)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Actavis Plc

ACT's Fundamental analysis






Actavis Plc's sales fell by -45.34 % in III. Quarter 2015 from the same quarter a year ago. Ranking at No. 441

Biotechnology & Drugs industry recorded growth of revenues by 27.87 %

Actavis Plc realized net income compared to net loss a year ago in III. Quarter 2015

More on ACT's Growth


Actavis Plc
realized net loss in trailing twelve months.

Actavis Plc realized cash outflow of $ -0.3per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 0.2.
Biotechnology & Drugs industry's Price to Sales ratio is at 4.14.

Actavis Plc Price to Book Ratio is at 0.84 lower than Indusry Avg. of 548.85. and higher than S&P 500 Avg. of -0.01

More on ACT's Valuation
 
 Total Debt (Millions $) 6,310
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 836,411
 Net Income/Employee (TTM) $ -74,026
 Receivable Turnover (TTM) 5.29
 Tangible Book Value (Per Share $) -31.51

Actavis Plc
realized net loss in trailing twelve months.

Actavis Plc realized cash outflow of $ -0.3per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 0.2.
Biotechnology & Drugs industry's Price to Sales ratio is at 4.14.

Actavis Plc Price to Book Ratio is at 0.84 lower than Indusry Avg. of 548.85. and higher than S&P 500 Avg. of -0.01

More on ACT's Valuation

 Market Capitalization (Millions $) 3,153
 Shares Outstanding (Millions) 134
 Employees 19,200
 Revenues (TTM) (Millions $) 16,059
 Net Income (TTM) (Millions $) -1,421
 Cash Flow (TTM) (Millions $) -40
 Capital Exp. (TTM) (Millions $) -182
 Total Debt (Millions $) 6,310
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 836,411
 Net Income/Employee (TTM) $ -74,026
 Receivable Turnover Ratio (TTM) 5.29
 Tangible Book Value (Per Share $) -31.51

 Market Capitalization (Millions $) 3,153
 Shares Outstanding (Millions) 134
 Employees 19,200
 Revenues (TTM) (Millions $) 16,059
 Net Income (TTM) (Millions $) -1,421
 Cash Flow (TTM) (Millions $) -40
 Capital Exp. (TTM) (Millions $) -182

ACT's Profitability Comparisons
Actavis Plc achieved increase in profitability, due to cost control. Operating Margin grew in III. Quarter 2015 to 7.73 %.

Actavis Plc net profit margin of 3.25 % is currently ranking no. in Biotechnology & Drugs industry, ranking no. in Healthcare sector and number 0 in S&P 500.


Profitability by Segment
Branded pharmaceutical products 33.38 %
Generic pharmaceutical products 12.09 %
Anda Distribution 3.58 %



  Ratio
   Capital Ratio (MRQ) 1.45
  Total Debt to Equity (MRQ) 1.69
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.19
  Inventory Turnover Ratio (TTM) 2.8



Actavis Plc achieved increase in profitability, due to cost control. Operating Margin grew in III. Quarter 2015 to 7.73 %.

Actavis Plc net profit margin of 3.25 % is currently ranking no. in Biotechnology & Drugs industry, ranking no. in Healthcare sector and number 0 in S&P 500.

More on ACT's Key Ratios





             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HDS's Profile

Stock Price

HDS's Financials

Business Description

Fundamentals

Charts & Quotes

HDS's News

Suppliers

HDS's Competitors

Customers & Markets

Economic Indicators

HDS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071